• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEALGEN SCIENTIFIC LLC CLINITEST RAPID COVID-19 ANTIGEN TEST; CLINITEST RAPID ANTIGEN SELF-TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEALGEN SCIENTIFIC LLC CLINITEST RAPID COVID-19 ANTIGEN TEST; CLINITEST RAPID ANTIGEN SELF-TEST Back to Search Results
Catalog Number 11561910
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cellulitis (1768)
Event Date 12/30/2022
Event Type  Injury  
Manufacturer Narrative
Udi could not be included in this report since customer did not provide covid test kit information.Siemens has requested more information from the customer to be able to perform further investigation.Both patients had used both nostrils for testing, and received negative results for covid which was confirmed during testing upon hospital admission.Both patients had multiple symptoms - headaches, rash, swelling.Per communication from customer, both received similar treatments.Hospital performed various tests to diagnose and confirm cellulitis.Per customer, patient 1 was admitted to hospital once only, however, patent 2 was hospitalized a second time for complications of cellulitis moving to her other eye with suspected infectious meningitis.The cause of this event is unknown.
 
Event Description
As holders of the emergency use authorization, siemens healthcare diagnostics is submitting this report on behalf of the manufacturer healgen scientific.Customer alleges siemens clinitest covid-19 antigen test is the cause of cellulitis to two children in her care.Per customer email, both patients used separate nasal swabs from the same test kit from lot2203174eua and endured same reaction within days leading to hospitalization.
 
Manufacturer Narrative
The manufacturer healgen has completed the investigation.Retained samples from lot 2203174eua were inspected, and no abnormalities were found.Batch records for lot 2203174eua were reviewed, and no abnormalities or associated deviations were found.Per the supplier investigation:- - swabs are packaged in plastic-paper bags in a clean room; they are then sent out for ethylene oxide (eo) sterilization.Following sterilization, the swabs undergo quality control testing, which includes several tests such as: appearance, physical dimension, material, swab head binding test, sterilization, eo residual test, and package.After the successful completion of the quality control checks, the swabs are released for shipment.- the swabs are sterilized using ethylene oxide (eo) sterilization process and tested according to iso 11737-2:2016 sterile test standard regulations.Additional documents included are sterilization statement (attachment 1) and biocompatibility statement (attachment 2).- three swab sterilization lots (20220226, 20220228, and 20220302) were used in the complaint lot 2203174eua.All three related sterilization lots passed sterilization testing and met all required quality control criteria.- a review of the materials used during manufacturing was conducted.No chemicals outside the substances in the bill of materials (bom) were used or came in contact with the product.- semi-finished products from the production line were inspected, and no abnormalities were identified.The product warehouse was also checked; no abnormalities were found.- the associated batch records were reviewed (by supplier), and no abnormalities or deviations were found.- the retained samples were reviewed, and also no abnormalities were found.Lastly, retained samples from the three swab sterilization lots (20220226, 20220228, and 20220302) were sent out for sterility testing.The results showed that the test articles had no detectable viable microorganisms under the test condition.For the reasons listed above, an issue with the swab or kit lot could not be confirmed.The cause of this event is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLINITEST RAPID COVID-19 ANTIGEN TEST
Type of Device
CLINITEST RAPID ANTIGEN SELF-TEST
Manufacturer (Section D)
HEALGEN SCIENTIFIC LLC
3818 fuqua st
houston TX 77047
Manufacturer (Section G)
ZHEJIANG ORIENT GENE BIOTECH CO. LTD.
#3784 east yangguang avenue
dipu street anji
huzhou, zhejiang 31330 0
CH   313300
Manufacturer Contact
cindy horton
3818 fuqua st
houston, TX 77047
MDR Report Key16294635
MDR Text Key308757138
Report Number3009238284-2023-00004
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210639
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number11561910
Device Lot Number2203174EUA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/19/2023
Initial Date FDA Received02/03/2023
Supplement Dates Manufacturer Received04/03/2023
Supplement Dates FDA Received04/06/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-